Cargando…
Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms
INTRODUCTION: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. OBJECTIVE: Our research was designed to study the protective effect of LTC against cerebral ischemi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463917/ https://www.ncbi.nlm.nih.gov/pubmed/34603791 http://dx.doi.org/10.1016/j.jare.2021.01.016 |
_version_ | 1784572498785861632 |
---|---|
author | Pan, Bo Sun, Jing Liu, Ziyu Wang, Lingxiao Huo, Huixia Zhao, Yunfang Tu, Pengfei Xiao, Wei Zheng, Jiao Li, Jun |
author_facet | Pan, Bo Sun, Jing Liu, Ziyu Wang, Lingxiao Huo, Huixia Zhao, Yunfang Tu, Pengfei Xiao, Wei Zheng, Jiao Li, Jun |
author_sort | Pan, Bo |
collection | PubMed |
description | INTRODUCTION: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. OBJECTIVE: Our research was designed to study the protective effect of LTC against cerebral ischemia–reperfusion (I/R) injury and reveal the underlying mechanism both in vivo and in vitro. METHODS: PC12 cells treated with glucose deprivation/reperfusion (OGD/R) were used to simulate in vitro ischemia/reperfusion (I/R) injury. The cell viability, apoptosis rate, and protein expressions of PC12 cells were evaluated. In vivo validation of the protective effect of LTC was carried out by middle cerebral artery occlusion (MCAO)/reperfusion treatment, and the underlying mechanism of its anti-apoptosis ability was further revealed by immunohistochemistry staining and Western blotting. RESULTS: In the current study, we observed that LTC effectively inhibited oxygen-glucose deprivation/reperfusion (OGD/R) induced apoptosis of PC12 cells through suppressing the cleavage of poly ADP-ribose polymerase (PARP), caspase-3, and caspase-9. Further investigation revealed that OGD/R insult remarkably triggered the endoplasmic reticulum stress responses (ER stress) to induce PC12 cell apoptosis. LTC treatment alleviated OGD/R induced ER stress by inhibiting the activation of protein kinase RNA (PKR)-like ER kinase (PERK)/eukaryotic translation initiation factor 2 (eIF2α) and inositol requiring enzyme 1 (IRE1)/tumor necrosis factor receptor-associated factor 2 (TRAF2) pathways. Additionally, LTC also restrained the OGD/R-induced PC12 cell apoptosis by reversing the activated mitogen-activated protein kinase (MAPK) through IRE1/TRAF2 pathway. Animal studies demonstrated LTC significantly restricted the infarct region induced by middle cerebral artery occlusion (MCAO)/reperfusion, the activation of ER stress and apoptosis of neuronal cells had also been suppressed by LTC in the penumbra region. CONCLUSION: LTC protects the cerebral neuronal cell against ischemia/reperfusion injury through ER stress and MAPK-mediated mechanisms. |
format | Online Article Text |
id | pubmed-8463917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84639172021-10-01 Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms Pan, Bo Sun, Jing Liu, Ziyu Wang, Lingxiao Huo, Huixia Zhao, Yunfang Tu, Pengfei Xiao, Wei Zheng, Jiao Li, Jun J Adv Res Pharmaceutical Science INTRODUCTION: Longxuetongluo Capsule (LTC) is wildly applied to treat ischemic stroke in clinical practice in China. However, the pharmacological mechanism of LTC on ischemic stroke is still unstated. OBJECTIVE: Our research was designed to study the protective effect of LTC against cerebral ischemia–reperfusion (I/R) injury and reveal the underlying mechanism both in vivo and in vitro. METHODS: PC12 cells treated with glucose deprivation/reperfusion (OGD/R) were used to simulate in vitro ischemia/reperfusion (I/R) injury. The cell viability, apoptosis rate, and protein expressions of PC12 cells were evaluated. In vivo validation of the protective effect of LTC was carried out by middle cerebral artery occlusion (MCAO)/reperfusion treatment, and the underlying mechanism of its anti-apoptosis ability was further revealed by immunohistochemistry staining and Western blotting. RESULTS: In the current study, we observed that LTC effectively inhibited oxygen-glucose deprivation/reperfusion (OGD/R) induced apoptosis of PC12 cells through suppressing the cleavage of poly ADP-ribose polymerase (PARP), caspase-3, and caspase-9. Further investigation revealed that OGD/R insult remarkably triggered the endoplasmic reticulum stress responses (ER stress) to induce PC12 cell apoptosis. LTC treatment alleviated OGD/R induced ER stress by inhibiting the activation of protein kinase RNA (PKR)-like ER kinase (PERK)/eukaryotic translation initiation factor 2 (eIF2α) and inositol requiring enzyme 1 (IRE1)/tumor necrosis factor receptor-associated factor 2 (TRAF2) pathways. Additionally, LTC also restrained the OGD/R-induced PC12 cell apoptosis by reversing the activated mitogen-activated protein kinase (MAPK) through IRE1/TRAF2 pathway. Animal studies demonstrated LTC significantly restricted the infarct region induced by middle cerebral artery occlusion (MCAO)/reperfusion, the activation of ER stress and apoptosis of neuronal cells had also been suppressed by LTC in the penumbra region. CONCLUSION: LTC protects the cerebral neuronal cell against ischemia/reperfusion injury through ER stress and MAPK-mediated mechanisms. Elsevier 2021-02-09 /pmc/articles/PMC8463917/ /pubmed/34603791 http://dx.doi.org/10.1016/j.jare.2021.01.016 Text en © 2021 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Pharmaceutical Science Pan, Bo Sun, Jing Liu, Ziyu Wang, Lingxiao Huo, Huixia Zhao, Yunfang Tu, Pengfei Xiao, Wei Zheng, Jiao Li, Jun Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms |
title | Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms |
title_full | Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms |
title_fullStr | Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms |
title_full_unstemmed | Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms |
title_short | Longxuetongluo Capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and MAPK-mediated mechanisms |
title_sort | longxuetongluo capsule protects against cerebral ischemia/reperfusion injury through endoplasmic reticulum stress and mapk-mediated mechanisms |
topic | Pharmaceutical Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463917/ https://www.ncbi.nlm.nih.gov/pubmed/34603791 http://dx.doi.org/10.1016/j.jare.2021.01.016 |
work_keys_str_mv | AT panbo longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT sunjing longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT liuziyu longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT wanglingxiao longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT huohuixia longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT zhaoyunfang longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT tupengfei longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT xiaowei longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT zhengjiao longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms AT lijun longxuetongluocapsuleprotectsagainstcerebralischemiareperfusioninjurythroughendoplasmicreticulumstressandmapkmediatedmechanisms |